State of the science in cervical cancer: Where we are today and where we need to go

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|120|15|2282-2288

ISSN: 0008-543x

Source: CANCER, Vol.120, Iss.15, 2014-08, pp. : 2282-2288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Invasive cervical cancer remains an important global cause of death, despite the declining prevalence within the United States. Definitive therapies, including surgical resection of early‐stage disease and chemoradiation for locally advanced disease, can be curative. For women who experience local or distant recurrences, the prognosis remains poor and better treatments are required. On July 18, 2013, The Gynecologic Oncology Group sponsored a State of the Science in Cervical Cancer Symposium with experts, researchers, clinicians, and interested stakeholders. This article summarize the progress that has been made, questions that require further investigation, and contemporary genomic findings and innovative treatments that may help inform the next generation of clinical trials for patients with cervical cancer. Cancer 2014;120:2282–2288. © 2014 American Cancer Society.